"This house believes that the current outsourcing of clinical trials to developing countries is flawed".
The motion: "This house believes that the current outsourcing of clinical trials to developing countries is flawed".
Find out next week what MBiotech students think!
For the motion: Team BioCitrix
Against the motion: IDIA Technologies
Hosts: bioLOGIX
Tuesday, March 19th, 2013, 6.30pm-8.00pm. Instructional Centre, Room 120. Open to the public.
The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this seminar series